Try our beta test site

ACCeptation and Qualitative Evaluation of Phone-delivered Intervention (ACCEPT-S)

This study is not yet open for participant recruitment. (see Contacts and Locations)
Verified January 2017 by Hôpital le Vinatier
Sponsor:
Collaborator:
Hospices Civils de Lyon
Information provided by (Responsible Party):
Hôpital le Vinatier
ClinicalTrials.gov Identifier:
NCT02949453
First received: October 24, 2016
Last updated: January 19, 2017
Last verified: January 2017
  Purpose
Background: Previous suicide attempt is known to be a strong risk factor for repetition and repetition is common within the first year after an episode of deliberate self-harm (DSH). There has been growing interest in brief interventions for this population that are focused on maintaining long-term contact and/or offering re-engagement with services when needed. Despite telephone-delivered interventions have shown promising results in suicide reattempt prevention, subjective impact of such brief contact interventions and effectiveness mechanisms have never been evaluated.

Condition Intervention
Suicide
Behavioral: Semi-directed interview performed by a social sciences researcher

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: No masking
Primary Purpose: Prevention
Official Title: ACCeptation and Qualitative Evaluation of Phone-delivered Intervention To Prevent Suicide Reattempt

Resource links provided by NLM:


Further study details as provided by Hôpital le Vinatier:

Primary Outcome Measures:
  • Acceptation of a telephone-delivered intervention after deliberate self-harm(DSH) [ Time Frame: change from baseline after the telephone intervention ]
    analyze the acceptability for suicidal patients in the reiteration of the suicide prevention procedure performed by telephone Callback


Secondary Outcome Measures:
  • Impact of telephone-delivered intervention after a deliberate self-harm (DSH) [ Time Frame: 2 years ]
    through the evaluation of this device Callback, we will identify its impact on pipelines and post-crisis experiences


Estimated Enrollment: 20
Anticipated Study Start Date: February 27, 2017
Estimated Study Completion Date: November 30, 2018
Estimated Primary Completion Date: November 30, 2018 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: patients after suicidal episode
Patients receiving a telephone-delivered intervention after deliberate self-harm (DSH)
Behavioral: Semi-directed interview performed by a social sciences researcher

Two semi-directed interviews performed by social sciences researcher:

  • first interview performed 6 weeks after the suicide attempt, in an suicide prevention unit, duration 1 to 1.5 hour
  • second interview performed 3 month after the suicide attempt, in a suicide prevention unit, duration 1 to 1.5 hour

Detailed Description:
Semi-structured in-depth interviews with 20 patients previously receiving a telephone-delivered intervention from our team. Six weeks and 3 months after a DSH, people included in telephone-delivered process will be interviewed by a social science researcher. Qualitative analysis using thematic analysis will be independently performed by two researchers.
  Eligibility

Ages Eligible for Study:   18 Years to 90 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Deliberate self-harm in the previous week,
  • 18 years old and older,
  • outpatient care orientation after discharge from emergency department

Exclusion Criteria:

  • Difficulties in french language,
  • mental retardation
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT02949453

Contacts
Contact: TERRA JEAN-LOUIS, PUPH 0033437915120 jean-louis.terra@ch-le-vinatier.fr
Contact: LEAUNE EDOUARD, CCA 0033437915120 edouard.leaune@ch-le-vinatier.fr

Sponsors and Collaborators
Hôpital le Vinatier
Hospices Civils de Lyon
Investigators
Principal Investigator: TERRA JEAN-LOUIS, PUPH CENTRE HOSPITALIER LE VINATIER
  More Information

Responsible Party: Hôpital le Vinatier
ClinicalTrials.gov Identifier: NCT02949453     History of Changes
Other Study ID Numbers: 2016-A00919-42
Study First Received: October 24, 2016
Last Updated: January 19, 2017
Individual Participant Data  
Plan to Share IPD: No

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by Hôpital le Vinatier:
suicide
prevention

Additional relevant MeSH terms:
Suicide
Self-Injurious Behavior
Behavioral Symptoms

ClinicalTrials.gov processed this record on March 29, 2017